Related Experiment Video
Updated: Nov 7, 2025

13:13
Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
14.2K
Screening methods for neonatal hyperbilirubinemia: benefits, limitations, requirements, and novel developments
Christian V Hulzebos1, Libor Vitek2, Carlos D Coda Zabetta3
1Beatrix Children's Hospital, University Medical Center Groningen, Groningen, The Netherlands. c.v.hulzebos@umcg.nl.
Pediatric Research
|May 4, 2021
Summary
Screening for severe neonatal hyperbilirubinemia (SNH) is crucial for early detection and treatment. Smartphone-based optical bilirubin estimation offers a promising, low-cost method for widespread SNH screening, especially in resource-limited settings.
Area of Science:
- Neonatal Medicine
- Biomedical Engineering
- Public Health
Background:
- Severe neonatal hyperbilirubinemia (SNH) is a global health concern requiring timely diagnosis.
- Visual jaundice assessment is unreliable; non-invasive screening is essential.
- Current advanced screening tools are often costly and inaccessible.
Purpose of the Study:
- To review current screening methods for SNH.
- To explore novel, low-cost screening technologies for SNH.
- To highlight the potential of smartphone-based bilirubin estimation for SNH screening.
Main Methods:
- Review of existing literature on transcutaneous bilirubin measurement.
- Discussion of emerging optical bilirubin estimation techniques using smartphone technology.
- Analysis of the potential impact of accessible screening tools on SNH prevention.
Main Results:
- Transcutaneous devices facilitate early SNH recognition but have limitations.
- Optical bilirubin estimation via smartphone apps shows promise for accurate TSB assessment.
- These methods can empower healthcare workers and parents in remote or home settings.
Conclusions:
- Non-invasive screening methods are vital for early SNH detection and management.
- Smartphone-based optical bilirubin estimation represents a potentially transformative, low-cost screening approach.
- All screening results must be confirmed by diagnostic methods before treatment initiation.

